BioSpace News Archive

Canadian farmers and food processors across the country work hard every day to put safe, high-quality food on our tables, while driving our economy and creating good, middle-class jobs.

Grand Opening Event debuting Artificial Intelligence-powered, virtual medical clinics inside Phoenix-area Safeway stores. Mayor Mark Mitchell to host ribbon cutting and make remarks.

Kewaunee Scientific Corporation announced today its Board of Directors declared a quarterly cash dividend of nineteen cents per outstanding share, payable on December 17, 2018 to stockholders of record at the close of business on December 4, 2018.

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of financial services software and software-enabled services, today announced that consistent with the quarterly dividend policy, its Board of Directors has approved a quarterly dividend of $0.08 per share.

- Presentations to be webcast on www.exelixis.com -

Mylan N.V. today announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall to the consumer level of select lots of Valsartan-containing products, including six lots of Amlodipine and Valsartan Tablets, USP (including the 5mg/160mg, 10mg/160mg, and 10mg/320mg strengths), seven lots of Valsartan Tablets, USP (including 40 mg, 80 mg, 160 mg, and 320 mg strengths), and two lots of Valsartan and Hydrochlorothiazide Tablets, USP 320mg/25mg strength.

Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that the Company will participate in two upcoming investor conferences.

Akebia Therapeutics, Inc. today announced that it will participate in the following investor conferences

Study published in Journal of Pain Research has important public health implications given current opioid epidemic in the U.S.

ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe, today announced its participation in the 30th Annual Piper Jaffray Healthcare Conference